BridgeBio Oncology Therapeutics Inc. (BBOT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Oncology Therap...

    NASDAQ: BBOT · Real-Time Price · USD
    12.36
    -0.08 (-0.64%)
    At close: Oct 03, 2025, 3:59 PM
    12.60
    1.94%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    BridgeBio Oncology Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 7.6M -41.69K -3.52K -74.33
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 271.57K n/a n/a n/a
    Other Working Capital
    		 -277.13K 15K n/a n/a
    Other Non-Cash Items
    		 -8.53M 26.69K 3.52K 74.33
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -104.61K 15K n/a n/a
    Operating Cash Flow
    		 -763.82K n/a n/a n/a
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -184M n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -184M n/a n/a n/a
    Debt Repayment
    		 -209.85K n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -578.55K n/a n/a n/a
    Financial Cash Flow
    		 186.46M n/a n/a n/a
    Net Cash Flow
    		 1.7M n/a n/a n/a
    Free Cash Flow
    		 -763.82K n/a n/a n/a

    Add to Watchlist